Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORTICA: Stress-dose steroids in in-hospital cardiac arrest
NCT02790788Phase 2Completed
- Sponsor
- National and Kapodistrian University of Athens
- Start
- Nov 2016
- Primary completion
- May 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of methylprednisolone and hydrocortisone in cardiac arrest (SCA), sponsored by National and Kapodistrian University of Athens. Primary endpoint: Early Postresuscitation Arterial Blood Pressure at 72 hours. Started Nov 2016; status: completed.
02
Drugs
methylprednisolonehydrocortisone
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT02790788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02790788.